|
Brain Tumors |
|
| Overview EpendymomaAstrocytoma CNS Lymphoma Colloid Cyst Craniopharyngioma Glioblastoma |
Hemangioblastoma Medulloblastoma Meningioma Metastatic Tumor Oligodendroglioma |
|
Recommend Web Sites Brain Science Foundation The Brain Tumor Society USC Affiliated Hospitals USC Health Information USC Norris Clinical Trials Pituitary Tumor Network Association Pubmed Caregiver resources Center for Caregiver Training Family Caregiver Alliance (California Only) Grief Net Hospice Alliance Hospice Hands Visiting Nurses Association Well Spouse Foundation Children’s Hospice |
Neuro-Oncology Program General Information Brain and spinal tumors, like many other cancers, come in a great variety of pathologic types, each necessitating a different approach to treatment that may require medical, surgical, or radiological intervention. As a result, an effective neuro-oncology program requires expertise in all of these therapeutic modalities. This expertise is available at USC/Norris Comprehensive Cancer Center and Hospital. The USC/Norris Neuro-Oncology program offers a comprehensive approach to caring for patients with brain tumors, bringing together medical neuro-oncologists, radiation oncologists and neurosurgeons to provide patients with a broad range of treatment options. Such an approach can be of great benefit to the patient, not only at the initial diagnosis and treatment, but also at time of relapse, should a tumor recur. Who We Are Thomas C. Chen, M.D., Ph.D. Thomas C. Chen, M.D., Ph.D., Neurosurgeon, specializes in neuro-oncology, treating a wide range of brain and spinal cord tumors. His clinical and research interests are three pronged: 1) using neuronavigational instrumentation and frameless strategic devices to localize brain tumors prior to open surgery; 2) performing clinical trials for the treatment brain tumors; 3) conducting translational lab research focusing on gliomas. Dr. Chen received his medical degree from the University of California, San Francisco, and completed his surgical internship and neurosurgical residency at USC, where he also earned his doctorate in experimental pathology. He then completed a one-year spine fellowship at the Medical College of Wisconsin before joining the USC faculty in 1997. He is currently a tenured associate professor of neurosurgery and pathology. Patient Centered Environment A key element of the USC/Norris Neuro-Oncology Program is the presence of the clinical nurse practitioner who stays in contact with the patient throughout the course of care, provides education and information for the patient and during treatment helps meet patient’s needs. Once the treatment is completed, the nurse practioner helps coordinate post-treatment care as well as link the patient to support groups and other community resources. Close Contact with Referring Physicians The USC/Norris Neuro-Oncology team is dedicated to staying in close touch with referring physicians, providing them with timely correspondence about the status of their patients. In addition, community-based physicians and specialists are encouraged to call our oncologic specialties for consultations on complex cases. Wide Range of Treated Tumors The USC/Norris Neuro-Oncology Program treats a wide range of brain tumors, including primary brain and spinal malignancies and metastatic complications. More specifically, we treat the following tumor types:
Malignant:
Primary Spine:
Secondary (metastases):
Wealth of Surgical and Radiological Expertise In excising brain tumors, our physicians have adopted the strategy of maximizing the use of pre-operative information to pinpoint the location of the tumor and minimizing the risk to surrounding areas of the brain. The USC/Norris Neuro Oncology program utilizes advanced neuronavigational technology and frameless stereotactic devices to better localize brain tumors. Making efficient use of magnetic resonance imaging (MRI), our surgeons substitute the traditional stereotactic frame, which must be anchored to the skull for scalp markers. A sophisticated neuronavigational computer software system then uses these multiple markers as registration points, translating a flat image into 3-D space. This approach enables the use of more local anesthesia to perform open brain surgery, thus avoiding the risks associated with general anesthesia. Another advantage of this technique to the patient is a shorter hospital stay. We use positron emission tomography (PET) and, for some tumors, MR spectroscopy to assess the metabolic status of the tumor. This information helps differentiate between tumor recurrence and tissue necrosis. Additionally, we use functional MR imaging in tumors involving eloquent areas of brain to better plan surgery. USC University Hospital is one of six facilities in California to offer an advanced Gamma Knife and only one of two in Los Angeles to feature its latest version, model C. In addition, USC is one of three centers in California offering cyberknife, stereotactic radiotherapy. Considered one the most significant developments in neurosurgery, this device is designed to deliver enough radiation to destroy the tumor while sparing adjacent, normal tissue. Providing surgeons with non-invasive method of treating inoperable brain tumors, the goal of gamma or cyberknife treatment is to reduce risk to the patient while maximizing the therapies effectiveness. USC is one of a handful of universities where the interventional neuroradiologists are part of the neuro-oncology team. These physicians specialize in the embolization of tumors of the brain. The lesions are treated and are then more amenable to surgical and radiological therapies. Description of Neuro-Oncology Program
Education Facts and Stats
Support Group Information: please call Kisha Smith (323) 865-3945 Contact Us Please submit all correspondence to: |
|
